Company news
Lobe Sciences Ltd news in 2025
Lobe Sciences Ltd's news releases, calls and decks from 2025, newest first.
Lobe Sciences Completes Debt Settlement to Improve Balance Sheet
October 23, 2025
Lobe Sciences Improves Balance Sheet
October 9, 2025
Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto
September 15, 2025
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
September 9, 2025
Lobe Sciences Announces the Appointment of Marco Mastrodonato to its Board of Directors
September 8, 2025
Lobe Sciences Announces the Closing of the Previously Announced Private Placement
August 14, 2025
Lobe Sciences Announces $341,425 CAD Private Placement for General Corporate Purposes
July 29, 2025
Lobe Sciences Ltd. Engages ArcStone Securities for Strategic Capital Markets Advisory
July 29, 2025
Lobe Sciences Ltd. Announces Debt Settlement
July 16, 2025
Lobe Sciences Announces Validation of European Unitary Patent for DHA-Based Composition for Sickle Cell Disease
July 8, 2025
Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals
June 17, 2025
Lobe Sciences Appoints Mr. Yong Yao as Chief Financial Officer to Support Strategic Growth
June 3, 2025
Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin
April 15, 2025
Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM)
April 14, 2025
Lobe Sciences Provides Corporate Update
April 4, 2025